Loading...
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients
Adjuvant bisphosphonate therapy is increasingly used in postmenopausal breast cancer patients. This is based on level-one evidence that bisphosphonates, particularly zoledronic acid, can effectively prevent cancer treatment-induced bone loss in breast cancer patients receiving estradiol-lowering end...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger GmbH
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132953/ https://ncbi.nlm.nih.gov/pubmed/21779211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000322099 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|